- Home
- CNTX vs SOL Comparison
CNTX vs SOL Comparison
Compare CNTX & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- SOL
- Stock Information
- Founded
- CNTX 2015
- SOL 2005
- Country
- CNTX United States
- SOL United States
- Employees
- CNTX 9
- SOL N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- CNTX Health Care
- SOL Technology
- Exchange
- CNTX Nasdaq
- SOL Nasdaq
- Market Cap
- CNTX 78.0M
- SOL 84.6M
- IPO Year
- CNTX 2021
- SOL 2008
- Fundamental
- Price
- CNTX $0.78
- SOL $1.48
- Analyst Decision
- CNTX Strong Buy
- SOL Buy
- Analyst Count
- CNTX 6
- SOL 3
- Target Price
- CNTX $6.50
- SOL $3.50
- AVG Volume (30 Days)
- CNTX 94.4K
- SOL 162.2K
- Earning Date
- CNTX 05-07-2025
- SOL 05-22-2025
- Dividend Yield
- CNTX N/A
- SOL N/A
- EPS Growth
- CNTX N/A
- SOL N/A
- EPS
- CNTX N/A
- SOL N/A
- Revenue
- CNTX N/A
- SOL $92,067,000.00
- Revenue This Year
- CNTX N/A
- SOL N/A
- Revenue Next Year
- CNTX N/A
- SOL $45.37
- P/E Ratio
- CNTX N/A
- SOL N/A
- Revenue Growth
- CNTX N/A
- SOL N/A
- 52 Week Low
- CNTX $0.55
- SOL $1.04
- 52 Week High
- CNTX $2.75
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- CNTX 45.08
- SOL 56.58
- Support Level
- CNTX $0.74
- SOL $1.25
- Resistance Level
- CNTX $0.85
- SOL $1.40
- Average True Range (ATR)
- CNTX 0.09
- SOL 0.07
- MACD
- CNTX -0.02
- SOL 0.03
- Stochastic Oscillator
- CNTX 13.67
- SOL 79.39
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.